Sofia Fund appeared to be the VC, which was created in 2006. The venture was found in North America in United States. The main department of described VC is located in the Minneapolis.
Among the various public portfolio startups of the fund, we may underline Cognition Therapeutics, Kidizen, Kenzen For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most successful fund investment fields, there are Therapeutics, Health Diagnostics. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager.
This organization was formed by Cathy Connett, Dee Thibodeau, Joy Lindsay, Lisa Crump. We also calculated 5 valuable employees in our database.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Sofia Fund, startups are often financed by Gaingels, Dolby Family Ventures, Xfund. The meaningful sponsors for the fund in investment in the same round are Golden Seeds, Xfund, Workday Ventures. In the next rounds fund is usually obtained by National Institute on Aging, Golden Seeds, Radius Ventures.
This Sofia Fund works on 9 percentage points less the average amount of lead investments comparing to the other organizations. The usual things for fund are deals in the range of 1 - 5 millions dollars. The fund is constantly included in less than 2 deals per year. The increased amount of exits for fund were in 2018. The high activity for fund was in 2016. Despite it in 2019 the fund had an activity.
Related Funds
Fund Name | Location |
Annex Ventures | Dallas, Texas, United States |
Caltex Australia | Australia, New South Wales, Sydney |
Contriber Ventures | Estonia, Tartu, Tartumaa |
Dentsu ScienceJam | Japan, Tokyo |
ICM Capital | England, London, United Kingdom |
IDI Emerging Markets | Luxembourg, Luxembourg |
Levy Restaurants | Chicago, Illinois, United States |
Limousin Business Angels | France, Limoges, Limousin |
Medical Technologies Innovation Asia | China, Hong Kong, Hong Kong Island |
Mohamad Moosa Abdulrahman Investment | - |
Nanjing Wuxiang Zichan | China, Jiangsu, Nanjing |
New Magellan Ventures | District of Columbia, United States, Washington |
Pear Ventures | California, Palo Alto, United States |
Phoenix Contact Innovation Ventures | Blomberg, Germany, Nordrhein-Westfalen |
Schreiber Foods | Green Bay, United States, Wisconsin |
Shanghai Luchang Touzi | China, Shanghai |
Sitka Partners | England, London, United Kingdom |
Techstars Detroit Accelerator | Detroit, Michigan, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Clinician Nexus | $1M | 19 Dec 2019 | Minneapolis, Minnesota, United States | ||
$13M | 26 Feb 2019 | New York, New York, United States | |||
Joylux | $5M | 22 Dec 2017 | Seattle, Washington, United States | ||
Kidizen | $3M | 09 Mar 2017 | Minneapolis, Minnesota, United States | ||
Oculogica | $1M | 17 Mar 2016 | New York, New York, United States | ||
Vixar | $2M | 30 Apr 2012 | Minnesota, United States | ||
Rebiotix | $2M | 15 Dec 2011 | Minnesota, United States | ||
New Moon | 19 May 2008 | Duluth, Minnesota, United States | |||
Tactile Medical | $11M | 30 Oct 2007 | Minneapolis, Minnesota, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Clinician Nexus | $1M | 19 Dec 2019 | Minneapolis, Minnesota, United States | ||
$13M | 26 Feb 2019 | New York, New York, United States | |||
Joylux | $5M | 22 Dec 2017 | Seattle, Washington, United States | ||
Kidizen | $3M | 09 Mar 2017 | Minneapolis, Minnesota, United States | ||
Oculogica | $1M | 17 Mar 2016 | New York, New York, United States | ||
Vixar | $2M | 30 Apr 2012 | Minnesota, United States | ||
Rebiotix | $2M | 15 Dec 2011 | Minnesota, United States | ||
New Moon | 19 May 2008 | Duluth, Minnesota, United States | |||
Tactile Medical | $11M | 30 Oct 2007 | Minneapolis, Minnesota, United States |